DOI QR코드

DOI QR Code

In Vitro N-Glycan Mannosyl-Phosphorylation of a Therapeutic Enzyme by Using Recombinant Mnn14 Produced from Pichia pastoris

  • Kang, Ji-Yeon (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Choi, Hong-Yeol (Department of Biological Engineering, Inha University) ;
  • Kim, Dong-Il (Department of Biological Engineering, Inha University) ;
  • Kwon, Ohsuk (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Oh, Doo-Byoung (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
  • 투고 : 2020.10.14
  • 심사 : 2020.10.22
  • 발행 : 2021.01.28

초록

Enzyme replacement therapy for lysosomal storage diseases usually requires recombinant enzymes containing mannose-6-phosphate (M6P) glycans for cellular uptake and lysosomal targeting. For the first time, a strategy is established here for the in vitro mannosyl-phosphorylation of high-mannose type N-glycans that utilizes a recombinant Mnn14 protein derived from Saccharomyces cerevisiae. Among a series of N-terminal- or C-terminal-deleted recombinant Mnn14 proteins expressed in Pichia pastoris, rMnn1477-935 with deletion of N-terminal 76 amino acids spanning the transmembrane domain (46 amino acids) and part of the stem region (30 amino acids), showed the highest level of mannosyl-phosphorylation activity. The optimum reaction conditions for rMnn1477-935 were determined through enzyme assays with a high-mannose type N-glycan (Man8GlcNAc2) as a substrate. In addition, rMnn1477-935 was shown to mannosyl-phosphorylate high-mannose type N-glycans (Man7-9GlcNAc2) on recombinant human lysosomal alpha-glucosidase (rhGAA) with remarkably high efficiency. Moreover, the majority of the resulting mannosyl-phosphorylated glycans were bis-form which can be converted to bis-phosphorylated M6P glycans having a superior lysosomal targeting capability. An in vitro N-glycan mannosyl-phosphorylation reaction using rMnn1477-935 will provide a flexible and straightforward method to increase the M6P glycan content for the generation of "Biobetter" therapeutic enzymes.

키워드

참고문헌

  1. Oh DB. 2015. Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases. BMB Rep. 48: 438-444. https://doi.org/10.5483/BMBRep.2015.48.8.101
  2. Chiba Y, Sakuraba H, Kotani M, Kase R, Kobayashi K, Takeuchi M, et al. 2002. Production in yeast of alpha-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease. Glycobiol. 12: 821-828. https://doi.org/10.1093/glycob/cwf096
  3. Tiels P, Baranova E, Piens K, Visscher CD, Pynaert G, Nerinckx W, et al. 2012. A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes. Nat. Biotechol. 30: 1225-1231. https://doi.org/10.1038/nbt.2427
  4. Zhu, Y. Zhu Y, Li X, Kyazike J, Zhou Q, Thurberg BL, et al. 2004. Conjugation of mannose 6-phosphate-containing oligosaccharides to acid alpha-glucosidase improves the clearance of glycogen in Pompe mice. J. Biol. Chem. 279: 50336-50341. https://doi.org/10.1074/jbc.M409676200
  5. Zhou Q, Stefano JE, Harrahy J, Finn P, Avila L, Kyazike J, et al. 2011. Strategies for neoglycan conjugation to human acid alphaglucosidase. Bioconjug. Chem. 22: 741-751. https://doi.org/10.1021/bc1005416
  6. Zhou Q, Avila LZ, Konowicz PA, Harrahy J, Finn P, Kim J, et al. 2013. Glycan structure determinants for cation-independent mannose 6-phosphate receptor binding and cellular uptake of a recombinant protein. Bioconjug. Chem. 24: 2025-2035. https://doi.org/10.1021/bc400365a
  7. Gil JY, Park JN, Lee KJ, Kang JY, Kim YH, Kim S, et al. 2015. Increased mannosylphosphorylation of N-glycans by heterologous expression of YlMPO1 in glyco-engineered Saccharomyces cerevisiae for mannose-6-phosphate modification. J. Biotechnol. 206: 66-74. https://doi.org/10.1016/j.jbiotec.2015.04.007
  8. Kim YH, Kang JY, Gil JY, Kim SY, Shin KK, Kang HA, et al. 2017. Abolishment of N-glycan mannosylphosphorylation in glycoengineered Saccharomyces cerevisiae by double disruption of MNN4 and MNN14 genes. Appl. Microbiol. Biotechnol. 101: 2979-2989. https://doi.org/10.1007/s00253-017-8101-3
  9. Laroy W, Contreras R, Callewaert N. 2006. Glycome mapping on DNA sequencing equipment. Nat. Protocols 1: 397-405. https://doi.org/10.1038/nprot.2006.60
  10. Choi HY, Park H, Hong JK, Kim SD, Kwon JY, You S, et al. 2018. N-glycan remodeling using mannosidase inhibitors to increase highmannose glycans on acid α-glucosidase in transgenic rice cell cultures. Sci. Rep. 8: 16130. https://doi.org/10.1038/s41598-018-34438-z
  11. Kang JY, Kwon O, Gil JY, Oh DB. 2016. Comparison of fluorescent tags for analysis of mannose-6-phosphate glycans. Anal. Biochem. 501: 1-3. https://doi.org/10.1016/j.ab.2016.02.004
  12. Shimma YI, Jigami Y. 2004. Expression of human glycosyltransferase gene in yeast as a tool for enzymatic synthesis of sugar chain. Glycoconj. J. 21: 75-78. https://doi.org/10.1023/B:GLYC.0000043752.89729.bb
  13. McVie-Wylie AJ, Lee KL, Qiu H, Jin X, Do H, Gotschall R, et al. 2008. Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease. Mol. Genet. Metab. 94: 448-455. https://doi.org/10.1016/j.ymgme.2008.04.009
  14. Togawa T, Takada M, Aizawa Y, Tsukimura T, Chiba Y, Sakuraba H. 2014. Comparative study on mannose-6-phosphate residue contents of recombinant lysosomal enzymes. Mol. Genet. Met. 111: 369-373. https://doi.org/10.1016/j.ymgme.2013.12.296
  15. Kang JY, Shin KK, Kim HH, Min JK, Ji ES, Kim JY, et al. 2018. Lysosomal targeting enhancement by conjugation of glycopeptides containing mannose-6-phosphate glycans derived from glyco-engineered yeast. Sci. Rep. 8: 8730. https://doi.org/10.1038/s41598-018-26913-4
  16. Zhu Y, Li X, McVie-Wylie A, Jiang C, Thurberg BL, Raben N, et al. 2005. Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice. Biochem. J. 389: 619-628. https://doi.org/10.1042/BJ20050364
  17. Kudo M, Canfield W. 2006. Structural requirements for efficient processing and activation of recombinant human UDP-N-acetylglucosamine: Lysosomal-enzyme-N-acetylglucosamine-1-phosphotransferase. J. Biol. Chem. 281: 11761-11768. https://doi.org/10.1074/jbc.M513717200
  18. Meel EV, Lee WS, Liu L, Qian Y, Doray B, Kornfeld S. 2016. Multiple domains of GlcNAc-1-phosphotransferase mediate recognition of lysosomal enzymes. J. Biol. Chem. 291: 8295-8307. https://doi.org/10.1074/jbc.M116.714568
  19. Liu L, Lee WS, Doray B, Kornfeld S. 2017. Engineering of GlcNAc-1-phosphotransferase for production of highly phosphorylated lsysosomal enzymes for enzyme replacement therapy. Mol. Thr. (Meth. Clin. Dev.) 5: 59-65. https://doi.org/10.1016/j.omtm.2017.03.006
  20. Wang XH, Nakayama KI, Shimma YI, Tanaka A, Jigami Y. 1997. MNN6, a member of the KRE2/MNT1 family, is the gene for mannosylphosphate transfer in Saccharomyces cerevisiae. J. Biol. Chem. 272: 18117-18124. https://doi.org/10.1074/jbc.272.29.18117
  21. Park JN, Song Y, Cheon SA, Kwon O, Oh DB, Jigami Y, et al. 2011. Essential role of YlMPO1, a novel Yarrowia lipolytica homologue of Saccharomyces cervisiae MNN4, in mannosylphosphorylation of N- and O-linked glycans. Appl. Env. Microbiol. 77: 1187-1195. https://doi.org/10.1128/AEM.02323-10